Skip to main content
International Journal of Molecular Sciences logoLink to International Journal of Molecular Sciences
. 2017 May 17;18(5):1069. doi: 10.3390/ijms18051069

The Regulatory Capacity of Bivalent Genes—A Theoretical Approach

Torsten Thalheim 1, Maria Herberg 1, Markus Loeffler 2, Joerg Galle 1,*
Editor: Nicoletta Sacchi
PMCID: PMC5454979  PMID: 28513551

Abstract

Bivalent genes are frequently associated with developmental and lineage specification processes. Resolving their bivalency enables fast changes in their expression, which potentially can trigger cell fate decisions. Here, we provide a theoretical model of bivalency that allows for predictions on the occurrence, stability and regulatory capacity of this prominent modification state. We suggest that bivalency enables balanced gene expression heterogeneity that constitutes a prerequisite of robust lineage priming in somatic stem cells. Moreover, we demonstrate that interactions between the histone and DNA methylation machineries together with the proliferation activity control the stability of the bivalent state and can turn it into an unmodified state. We suggest that deregulation of these interactions underlies cell transformation processes as associated with acute myeloid leukemia (AML) and provide a model of AML blast formation following deregulation of the Ten-eleven Translocation (TET) pathway.

Keywords: bivalent gene, histone modification, gene expression heterogeneity, lineage specification, aberrant DNA methylation, blast formation

1. Introduction

In the last decade, different histone modifications have been implicated in transcriptional regulation of genes. In this regard, tri-methylation of lysine 4 and 27 at histone H3 are well studied modifications [1]. Tri-methylation of lysine 4 at histone H3 (H3K4me3), if present at nucleosomes that are associated with CpG-rich gene promoters, has been found to be positively correlated with the transcription of the respective gene. In contrast, tri-methylation of lysine 27 at histone H3 (H3K27me3), if present at these nucleosomes, is often associated with gene repression. Experimentally, a non-linear, approximately sigmoidal relationship between gene transcription and the modification level of the gene promoter has been observed for both the H3K4me3 and the H3K27me3 modification [2]. Thereby, the modification level of H3K4me3 at the promoter of a gene changes from low to high, when the transcription rate of the gene exceeds a particular threshold. The opposite holds true for the modification level of H3K27me3.

It has been shown that both the H3K4me3 and the H3K27me3 modification are set by specific methyltransferase complexes (tri-thorax and polycomb group complexes, respectively) that can not only write but also read the modification [1]. This capability results in a positive feedback on writing the modification. Such feedback enables bi-stability, i.e., the coexistence of two stable modification states. Accordingly, cells can either carry a modified or an unmodified gene under the same, defined conditions. We have predicted that the occurrence of bi-stable modification states depends, e.g., on the histone (de)-modification rates, the methylation of the associated DNA or the number of nucleosomes that are cooperatively modified [3].

Genes that carry both the H3K4me3 and the H3K27me3 modification at nucleosomes associated with their promoter region are called bivalent and typically show an intermediate gene expression. Initially, bivalency has been described as a “zonal” phenomenon only, in which a broad domain of H3K27me3 surrounds a narrower one of H3K4me3. However, it has been demonstrated recently that both modifications indeed can reside at the same nucleosome [4]. We here focus on such truly bivalent nucleosomes being often enriched in the vicinity of the transcription start site of a gene [5]. Bivalent genes have come into research focus because they often change their modification state from bivalent to monovalent during developmental processes [6]. These dynamic state changes are accompanied by alterations in the transcription of the affected gene. Loss of H3K27me3 is accompanied by transcriptional activation of the gene, while a loss of H3K4me3 is related to its transcriptional repression. Well known examples of bivalent genes are genes encoding transcription factors (TFs) involved in developmental and stem cell differentiation processes, such as GATA3 [7] and Achaete-scute complex homolog 2 (ASCL2) [8] being involved in hematopoietic and intestinal lineage specification, respectively, or ATOH1 controlling sensory hair cell differentiation [9]. Findings on such TFs suggest an instructive role of bivalent histone modifications regarding cell fate decisions by controlling heterogeneous gene expression. Nevertheless, a mechanistic understanding of this control process is still largely missing.

In the following, we introduce a theoretical model of bivalency to gain a mechanistic understanding of the link between histone modification and transcriptional regulation. In particular, we analyze the stability of the bivalent state depending on the properties of the histone modification and transcriptional machinery. By computational simulation, we demonstrate: (i) that the regulatory circuit can induce stable gene expression heterogeneity in proliferating cell populations by (reversible) transitions from the bivalent modification state into the monovalent states; and (ii) that these transitions are a consequence of a particular kind of asymmetric cell division randomly distributing modified histones from the mother onto the daughter cells. Subsequently, we investigate the role of DNA methylation in this process. We show: (i) that following DNA methylation the bivalent state becomes destabilized; and (ii) that under these conditions gene expression heterogeneity can be induced by active DNA demethylation. Our findings have implications for a better understanding the control and deregulation of cell population heterogeneity as observed, e.g., in the hematopoietic stem cell system and during tissue transformation, as e.g., blast formation in acute myeloid leukemia (AML).

2. Basic Model Assumptions

2.1. Epigenetic Regulation of Transcription: The Basic Regulatory Circuit

In the following, we built on an established theoretical model of histone methylation, which has been introduced by our group previously [3,10]. This model, which applies to histone modifications of CpG-rich gene promoters, considers dynamic histone modification states due to permanent histone de-modification processes. It quantifies modification levels as the fraction of modified nucleosomes associated with the promoter. The modification processes are described in dependence of binding properties of the histone methyltransferase (HMT) complexes to nucleosomes and the associated DNA, which change depending on their respective methylation state. Details on the basic model system can be found in [3].

In an extension of the model [11], we have recently introduced a positive feedback loop between the transcriptional activity of the gene (T) and the H3K4me3 modification level (m4). Based on experimental findings, we assumed that transcriptional activity facilitates recruitment of H3K4me3 HMTs [12] and that H3K4me3 contributes in recruiting Pol II [13]. In the following, we assume a negative feedback loop between transcriptional activity (T) and the H3K27me3 level (m27) in addition. We assume that transcriptional activity suppresses the recruitment of the H3K27me3 HMTs and that H3K27me3 impedes recruitment of Pol II. In fact, binding of activating TFs in the promoter region has been reported as a major factor suppressing H3K27me3 modification [14]. Moreover, polycomb group complexes, containing the HMTs of H3K27me3, have been suggested to suppress transcription by preventing the binding of acetyl-transferases to target genes [15].

In a first version of the model (MV1, Figure 1A), we neglect effects of DNA methylation at the gene promoter. We describe genes that are effectively protected from DNA methylation independent of the histone modification states of the associates nucleosomes; as genes that undergo permanent DNA demethylation, e.g., due to the activity of Ten-eleven Translocation (TET) proteins (reviewed in [16]). We do not consider explicit interdependencies between the two histone modifications.

Figure 1.

Figure 1

Sketch of the interactions within the regulatory circuit. (A) The simplified model version MV1 focuses on the interaction between histone modification and transcription, while effects of DNA methylation are neglected. We consider a positive feedback (green arrows) between H3K4me3 and transcription and a negative one (red T bars) between H3K27me3 and transcription; (B) In an extended model version MV2, both histone modifications are considered to be suppressed by DNA methylation that weakens binding of the respective HTMs. H3K4me3 suppresses DNA methylation by suppressing DNA methyltransferase (DNMT) recruitment, while H3K27me3 recruits DNMTs.

This model constraint will be released in a second version of the model (MV2, Figure 1B) that includes interactions between histone and DNA methylation at the gene promoter. In order to describe the DNA methylation level of the gene promoter mDNA, i.e., the fraction of methylated CpGs at the promoter, we basically use the same mathematical formulation of the DNA methylation machinery as described in [10]. Thus, we consider maintenance and de novo DNA methylation, controlled by the DNA methyltransferases 1 (DNMT1) and 3a,b (DNMT3a,b), respectively. Both processes are assumed to be active during cell division only. In accordance with experimental observations, we assume DNA methylation to be subject to regulatory feedback loops with both H3K4me3 and H3K27me3. We assume that H3K4me3 suppresses binding of de novo DNMTs [17] and that DNA methylation weakens the binding of H3K4me3 HMTs to DNA [18]. The latter is assumed also for H3K27me3 HMTs [14]. In contrast to H3K4me3, H3K27me3 is assumed to contribute in recruiting de novo DNMTs, and thus destabilizes itself. This is in agreement with experimental findings showing that the H3K27me3 HMT Enhancer of zeste homolog 2 (EZH2) recruits DNMTs, but the DNMTs subsequently do not induce de novo DNA methylation before H3K27me3 is removed [19].

DNA methylation is assumed to have no direct impact on transcription. This assumption is in agreement with experimental findings, which show that transcriptional silencing of promoters precedes their DNA methylation [20].

2.2. Simulations of Cell Populations

We analyze the dynamics of transcription, histone modifications and DNA methylation in a small cell population of 100 cells by stochastic simulations of the behavior of the bivalent circuit. One simulation consists of 10,000 simulation steps. We record the state of the cells every 100 simulation steps, here referred as one time step. Thereby, changes of the regulatory state of an individual cell originate in fluctuations of the histone methylation states that depend on the methylation state of the associated DNA and on gene transcription. We neglect all other types of permanent fluctuations, e.g., fluctuations in Pol II binding [21]. Fluctuations of histone modifications are simulated considering modification and de-modification of individual histones that are associated with the gene promoter with rate kmod θK and kde, respectively. Here, kmod and kde are constants and θK (K = 4, 27) is the binding affinity of the respective HMT [3]. Subsequent changes in DNA methylation and transcription are simulated according to differential equations given in the text below. The regulatory states are mapped on discrete cell fates (e.g., the bivalent state) that define subpopulations of cells.

It has been shown experimentally that during cell division the histones of the mother cell are randomly distributed onto the two daughters [22]. Accordingly, cell division results in a strong dilution of the modified histones in both daughter cells. We simulated these effects of cell division by performing a dilution of the modified histones after a (gamma-distributed) waiting time, i.e., after cell cycle time τ [23]. Whenever one daughter cell retains a fraction x of the modified nucleosomes present in the mother, the other daughter retains a fraction (1 − x). We consider that the cells compete for space within their niches. Accordingly, we keep the total number of cells fixed assuming that each increase due to a cell division event is exactly balanced by cell loss from the niche. Thereby, subpopulations might differ in their specific cell loss probability.

3. Results

3.1. The Occurrence of the Bivalent Modification States

Our model is consistent with the experimental finding of a non-linear, approximately sigmoidal relationship between gene transcription and the modification level of the gene promoter; for both the H3K4me3 and the H3K27me3 modification [2]. The H3K4me3 (H3K27me3) modification level of a gene changes from low to high (high to low), when its transcription rate exceeds a particular threshold. Depending on the transcriptional level at which this change occurs for the individual modification, here referred as TK (K = K4, K27), one can, in general, distinguish two cases (Figure 2A).

Figure 2.

Figure 2

Occurrence of the bivalent state: (A) Shown are the H3K4me3 (red) and H3K27me3 (blue) modification levels for different binding efficiencies of the HMTs. Intersections with the black line mmax/2 define TK (K = K4, K27). For TK27 < TK4 (System A1, thin lines) an unmodified state is associated with transcription levels TK27 < T < TK4 (box with horizontal lines), while for TK27 > TK4, (System A2, thick lines) a bivalent state is associated with transcription levels TK4 < T < TK27 (box with vertical lines); (B) Increasing the number of cooperative nucleosomes at the promoter, here for system A1, enforces bistable modification states (red: H3K4me3, blue: H3K27me3). They can occur as exclusive solutions (range II) or can co-occur with one of the monovalent states (ranges I: K27 and III: K4). These states are hard to measure experimentally as averages over many cells will pretend intermediate modification levels.

In the case TK27 is smaller than TK4 (System A1) one observes an “unmodified” state for transcription levels between TK27 and TK4. In this state the nucleosomes associated with the gene promoter are neither H3K4me3 nor H3K27me3 modified. Increasing the transcription in this case, the promoter modification state will change from “H3K27me3” to “unmodified” to “H3K4me3”. In the opposite case, where TK27 is larger than TK4 (System A2), one observes a “bivalent” state for transcriptional levels between TK4 and TK27. In this state, the nucleosomes associated with the gene promoter are H3K4me3 and H3K27me3 modified.

Which of these cases is actually realized for a particular gene depends, among others, on the promoter accessibility for HMTs. Thus, system A1 (Figure 2A, thin lines) can be changed to system A2 (Figure 2A, thick lines) just by assuming a more open chromatin state (see: Appendix A). Accordingly, our model predicts that cells with an open chromatin state, such as embryonic stem cells (ESC), will have more bivalent genes than cells with more condensed chromatin, in agreement with experimental observations [24]. Another way to induce bivalent states is increasing the cooperativity of HTM binding and thereby inducing bi-stable states of the both histone modifications (Figure 2B, regions I and III, [3]). In the System A1 (Figure 2A), such an increase of the cooperativity switches the unmodified state, seen for transcriptional levels between TK27 and TK4 into a bivalent state (Figure 2B, region II). Our further studies are focused on systems with high cooperativity of HTM binding.

3.2. Balance between Histone Modification States (the Histone Modification Machinery)

In our model each value of the H3K4me3 modification level (m4) and the H3K27me3 modification level (m27) is associated with a well-defined transcription level T1(m4) and T2(m27), respectively, via a self-consistent equation. In contrast, due to potential bi-stability of the modifications, a specific transcription level can be associated with either one or three different modification levels (compare: Figure 2). The explicit functions T1(m4) and T2(m27) used in our model are given in the Appendix A. All modification states, i.e., all pairs {m4*, m27*}, which can be realized given a particular organization of the histone modification machinery, need to solve the equation:

T1(m4*;{X})=T2(m27*;{X}) (1)

Thereby, the solutions depend on the parameter set {X}. Among these parameters are the binding energies of the HMTs, the histone (de-)modification rates and the number NH of cooperative nucleosomes associated with the gene promoter. Examples of the set of possible modification states {m4*, m27*} are shown in Figure 3A for genes with different numbers of cooperative nucleosomes NH. For NH > 5, bi-stable regions for m4 and m27 are induced (compare: Figure 2B). Thus, for a limited range of m4 (m27) three possible pairs {m4*, m27*} exist for each value of m4 (m27). Under the same conditions, a range of bivalent states becomes manifest that extents with increasing NH. The full parameter sets {X} applied in these examples are given in Table A1.

Figure 3.

Figure 3

The bivalent state in MV1: (A) Shown are the possible pairs {m4*, m27*} applying parameter set {X} for different numbers (NH = 4 (orange), 12 (green), and 20 (black)) of the cooperative nucleosomes associated with the promoter. The range of m4 and m27 is exponentially spread approaching its maximum and minimum values (see: Appendix A). The boxes indicate the specific modification states; (B) Transcription states derived applying parameter set {Y} for NH = 20 without (brown: NTF = 0) and with (black: NTF = 3) transcriptional auto-feedback. The solutions are given as the intersections of the functions g with the function y = x (dots); (C) Solutions of Equations (1)–(3) in the {m4, m27} space. The solid (open) dots on the curve indicate the stable (unstable) fix points for NTF = 3. The transcriptional level of all other pairs is color coded; (D) Transcriptional activation (brown line, FTF = 4); and (E) repression (black line, FTF = 1/4) changes the solutions quantitatively as well as qualitatively. (D,E) References (FTF = 1) are shown as grey lines; (F) Solutions of Equations (1)–(3) and fix points for the system shown in (E).

3.3. Transcription Controls Epigenetics (the Transcriptional Machinery)

According to the assumptions described above, the histone modification machinery defines all possible modification states that potentially can be realized. Which of them actually become realized is defined by the transcriptional machinery. The fix points of the modeled regulatory circuit {m4#, m27#, T#} are the solutions of the equation:

dT/dt=f(m4*,m27*,T;{Y})=0 (2)

Here, dT/dt is the time derivative of T and {Y} refers to the parameter set describing the transcriptional machinery. Among the parameters of {Y} are the maximum promoter activity of a gene and the effective transcript degradation rate. In case a gene encodes a TF that auto-activates itself—which is observed for several key developmental or differentiation regulators, such as the TFs PU.1 or ASCL2 [25,26]—the parameter set {Y} contains also the parameters describing this kind of feedback; as e.g., the number NTF of TF binding sites contained in the gene promoter that are bound by the TF encoded by the gene itself.

As m4 and m27 depend on T, solving Equation (2) in general requires solving a self-consistent equation:

T#=g(m4#,m27#,T#;{Y}) (3)

Details about the functions g applied in our study are given in the Appendix B. Figure 3B shows typical solutions of Equations (1)–(3) for different degrees of auto-activation (NTF = 0 and 3). The gene without auto-activation (NTF = 0) possesses three transcriptional states; two of them being stable and one being unstable. The stable, low expression state is associated with an H3K27me3 state and the intermediate expression state with a bivalent one. Introducing auto-activation (NTF = 3) enables a third stable state—a high expressing H3K4me3 state—and increases the expression level of the bivalent state. Figure 3C shows the localization of the obtained solutions and their transcriptional level in the {m4, m27} space. It can be seen that: (i) H3K27me3 states are always related to low gene expression; (ii) the H3K4me3 states are associated with high gene expression; and (iii) the bivalent states show a broad range of intermediate expression values. For the chosen parameter set {X}, there exists no stable unmodified state independent of the chosen parameter set {Y}. The set {Y} applied in these examples is given in Table A2.

The described circuit can control transitions between regulatory states characterized by different histone modification levels and, thus, transcriptional activities. Such transitions can be induced, e.g., by a TF network that is linked to the gene of interest [10]. The modification states and the transcriptional activity of such a “network-driven” genes are shown in Figure 3D–F. The gene that is solely activated by the TF network (NTF = 0, FTF = 4, Figure 3D) has only a single stable bivalent state. However, small changes of its transcriptional activity can induce state transitions. In particular, an increase (decrease) of less than 35% of the transcriptional activity through the background TF network enables the gene to switch into a monovalent H3K4me3 (H3K27me3) state. This option does not exist for the reference gene (FTF = 1), which can only switch between a bivalent and a monovalent H3K27me3 state. The gene with auto-feedback that is repressed by the background TF network (NTF = 3, FTF = 1/4, Figure 3E) possesses a bivalent state with low transcriptional activity, while the reference system (FTF = 1) shows a bivalent state with high activity. Thus, switches into H3K4me3 and H3K27me3 states will occur with different frequencies. Figure 3F shows the localization of the fix points following gene repression and their transcriptional level in the {m4, m27} space. Remarkably, for genes that are slightly less repressed, two stable bivalent states can be observed, i.e., multiple bivalent states can exist for a single gene that is embedded in a larger regulatory network structure.

Changes between the stable states require fluctuations of the histone modification level. Details on the stability of the fix points of the system under permanent histone (de-)modification are given in Appendix C. These results demonstrate that, for the applied parameter sets, the bivalent states are more or less long term stable. Hence, cell division-related fluctuation, i.e., cell division-related dilution of modified nucleosomes, are required to resolve the bivalent states. This effect was considered in the following stochastic simulations.

3.4. Histone Modification Can Instruct Gene Expression

Epigenetic lineage priming and specification have been described for different stem cell systems including the hematopoietic system [27]. Thereby, resolution of bivalent chromatin states of TFs has particularly been associated with T-cell specification. The maybe best analyzed example is GATA3 [7,27,28]. The promoter of this gene is bivalent modified in hematopoietic stem cells (HSCs), multipotent (MPPs) and common lymphoid progenitors (CLPs) as well as in B-cells and becomes activated, i.e., it loses H3K27me3, in T-cells. In contrast, GATA3 expression becomes repressed, i.e., its promoter loses H3K4me3, in common myeloid (CMPs), granulocyte-macrophage (GMPs), and megakaryocyte-erythroid Progenitors (MEPs). Moreover, GATA3 is auto-activated [29] and the promoter DNA of GATA3 remains unmethylated in all analyzed cell types [28]. Thus, resolving the bivalent mark at nucleosomes associated with the GATA3 promoter during proliferation can serve as an example of an instructive role of histone modifications regarding gene expression. If the promoter loses the H3K27me3 marks, GATA3 expression becomes up-regulated. Up-regulation of GATA3 increases the potential to specify into T-cell lineages [30]. If the promoter loses the H3K4me3 marks, GATA3 expression becomes down-regulated and the cell starts to specify more likely into the myeloid lineage [31].

In order to study the establishment and long-term maintenance of such a heterogeneous cell population, we translated the experimental findings on a GATA3-dependent lineage specification into a general model. As illustrated in Figure 4A, the model accounts for three different cell types that are defined by their histone modification state: bivalent stem cells (SC), H3K27me3-monovalent, pro-myeloid progenitors (P1), and H3K4me3-monovalent, pro-lymphoid progenitors (P2). Furthermore, we assumed that all cell types proliferate with an average cell cycle time τ0 of 2.5 time steps (250 simulation steps). Subsequent to each cell division P1 or P2 cells leave the system providing space for the daughters.

Figure 4.

Figure 4

An instructive role of histone modification for GATA3 expression heterogeneity: (A) Sketch of the model of GATA3 heterogeneity. All cells proliferate. Expansion of the compartment is balanced by loss of pro-myeloid progenitors (P1) or pro-lymphoid progenitors (P2) cells that change into a differentiated compartment; (BF) Simulation results for a system with stable self-renewal of the bivalent GATA3 state (SC); (B) Simulated distribution of GATA3 expression in the proliferative compartment at t = 100 (see: DF). All three states, SC, P1 and P2, are observed; (C) Bimodal distributions of H3K4me3 and H3K27me3 states are observed within the population; (D,E) Time dependent composition of the population as seen for: transcription (D); H3K4me3 (E); and H3K27me3 (F) modification (color coded). Shown are cell numbers averaged over 50 simulations with 100 cells each. Black lines separate the cell types based on transcription levels: P1 < 0.01 ≤ SC ≤ 1 < P2.

Starting from a homogeneous cell population of bivalent SCs, over time a heterogeneous, albeit dynamically stabilized cell population is established. This heterogeneity inherently emerges due to a random loss of H3K4me3 or H3K27me3 modifications in individual cells after cell division, which leads to bimodal H3K4me3 and H3K27me3 distributions as shown in Figure 4C. As transitions from the bivalent to a monovalent histone modification state are directly linked to changes in gene expression, the different cell types can also be distinguished based on their transcriptional activity (Figure 4B). In the model, bivalent SCs are characterized by an intermediate transcription (0.01 < T < 1), while P1 cells express low levels (T < 0.01) and P2 cells high levels (T > 1) of GATA3 (Figure 4B) closely mimicking experimental results. In contrast to typical flow cytometry measurements, which can only provide a snapshot of the population heterogeneity, computer simulations allow monitoring the dynamic changes of transcriptional (Figure 4D) and epigenetic states (Figure 4E,F) over time. It can be seen that the heterogeneity of the cell population remains long-term stable.

Systematic imbalance of the expression states of GATA3 can lead to disease. For example, loss of GATA3 induces B cell lymphoma [32]. This can be due to changes in the histone modification machinery [33]. Examples of related simulations are given in the Appendix D (Figure A4).

3.5. DNA Methylation Destabilizes Bivalent States

Thus far, we have neglected DNA methylation. However, transcription of many genes has been demonstrated to be affected by DNA methylation. In particular, methylation of CpG-rich promoters is frequently accompanied by repression of the associated gene [16]. Moreover, age-related changes in DNA methylation can be predicted by histone modification states in young individuals [34]. Thus, we considered effects of promoter DNA methylation on bivalent histone modification in a second model version (MV2).

In this setting, we describe changes of the fraction mDNA of methylated CpGs at the gene promoter, neglecting effects of stochastic methylation of individual CpGs [35]. As consequence of the interactions between histone modifications and DNA methylation (Figure 1B), all possible modification states of the gene, i.e., all triples {m4*, m27*, mDNA*}, need to solve, beside Equations (1)–(3), the equation:

τdmDNA/dt=H(m4*,m27*,mDNA*;{Z})=0 (4)

where dmDNA/dt is the time derivative of mDNA and {Z} refers to the parameter set describing the DNA methylation machinery. This set includes the probability of de novo DNA methylation Dnovo and the probability of maintaining DNA methylation Dmain. The parameter set {Z} is given in Table A3. A general difference compared to the system without DNA methylation is that the two histone states are now linked not only via transcription but also via DNA methylation. Details can be found in Appendix E.

Figure 5A shows all possible pairs {m4*, m27*} for such a regulatory system, using the same parameter set as in the unmethylated system (Figure 3A–C) for a fixed number of cooperatively acting nucleosomes (NH = 20). It can be seen that with increasing de novo DNA methylation activity unmodified states become possible, where the nucleosomes carry neither H3K4me3 nor H3K27me3. For the system with a de novo DNA methylation probability of 0.3, four stable states are observed (Figure 5B,C); among them, two intermediate expressing states that are distinguished by their DNA methylation level. The bivalent state shows low, while the unmodified state shows high methylation.

Figure 5.

Figure 5

The bivalent state in MV2: (A) Shown are all possible modification states applying the parameter sets {X} and {Z}. Increasing de novo DNA methylation probabilities Dnovo (black: 0, dark yellow: 0.1, violet: 0.3), unmodified states become possible and bivalent states move to lower modification levels; (B) Shown is the transcription associated with the modification states; and (C) the DNA methylation level of the CpGs of the associated promoter for Dnovo = 0.3. Values are color coded. The solid (open) dots on the curve indicate the stable (unstable) fix points of the system observed for parameter set {Y}.

As discussed above, state fluctuations are required to switch between the stable modification states. In simulations, we observed that DNA methylation reduces the stability of the bivalent state against fluctuations. The basin of attraction of the bivalent state shrinks and the state becomes less frequent populated (see: Appendix C, Figure A2). Thus, in the model, DNA methylation has similar effects on bivalent states as chromatin compaction (compare: Figure 2A and Appendix A) but can occur independently. In cells these events are often linked [24].

3.6. A Model of Blast Formation during AML

Besides GATA3, PU.1 is a second gene encoding a major TF responsible for specification into either the myeloid or the lymphoid lineage. In HSCs and MPPs the PU.1 promoter is associated with H3K4me3 only and accordingly the gene is expressed [27]. In myeloid progenitors PU.1 expression becomes further up-regulated, while in T-cell progenitors the gene becomes down-regulated [36]. In T-cells, the promoter loses H3K4me3 [27] and becomes methylated [37]. PU.1 can become auto-activated because it encodes a TF that binds back to its promoter [25]. This binding was suggested to result in recruitment of TET2-proteins and subsequently in active demethylation of the promoter in all cells where PU.1 is activated [38]. Strikingly, in myeloma cells, PU.1 becomes down-regulated and methylation of the PU.1 promoter is found similar to T-cells [39]. Based on these observations, we suggest a mechanistic model of TET2 mutation associated AML.

Figure 6A shows a sketch of a model of undisturbed PU.1 regulation (SC: unmodified, multi-potent progenitors: 0.01 < T < 1, P1: H3K4me3-monovalent, pro-myeloid progenitors: T < 0.01, P2: H3K27me3-monovalent, pro-lymphoid progenitors: T > 1), which considers both DNA methylation and demethylation. Thereby, DNA demethylation occurs permanently and its rate is assumed to be proportional to the expression of the PU.1 gene as suggested by the experimental finding mentioned above (see also: Appendix E). As in the GATA3 model, we assume that all cell types proliferate and that subsequent to each cell division (if available) only P1 or P2 cells are transferred into a differentiated compartment, providing space for the daughters.

Figure 6.

Figure 6

Model of blast formation: (A) Sketch of the assumed model of PU.1 regulation. Note that DNA demethylation is expression dependent. As in the GATA3 model, only P1 and P2 cells exit the proliferative compartment; (B,C) PU.1 regulation in undisturbed cells. Stable high expression (P1) is enabled by permanent active DNA demethylation. In P2 cells PU.1 is repressed by H3K27me3 and DNA methylation; (D,E) PU.1 regulation in blast cells. Loss of active DNA demethylation (at t = 50) compromises PU.1 activation and leads to expansion of SC-like blasts SC’; (BE) Shown are cell numbers averaged over 50 simulations with 100 cells each. Colors encode expression (B,D) or DNA methylation (C,E). Black lines separate the cell types based on transcription levels: P1 < 0.01 ≤ SC ≤ 1 < P2.

Simulation results of that model are shown in Figure 6B,C. In contrast to the GATA3 model, SCs are characterized by an unmodified and partially DNA methylated state. A bistable state is not observed because both H3K4me3 and H3K27me3 have been destabilized by DNA methylation. In committed cells, PU.1 becomes either up-regulated (P1) following gain of H3K4me3 or down-regulated (P2) following gain of H3K27me3 (Appendix F, Figure A5A,B). Thereby, gain of modification is enabled as a consequence of the ongoing active DNA demethylation between two cell division events. Thus, it depends on the cell cycle time τ. Increasing τ, such that DNA demethylation is effective even for slowly demethylating promoters of repressed genes (compare: Appendix E, Equation (A9)), the bivalent state becomes stabilized (Appendix F, Figure A5C,D). In contrast to the GATA3 system, an expansion of the SC state is observed, accelerating and not decelerating proliferation (Appendix F, Figure A6).

To model blast formation, we assume that active DNA demethylation is no longer functional, e.g., according to mutations in the gene encoding TET2 [40]. Consequently, the promoter of the PU.1 gene, as other promoters being under the control of active DNA demethylation by TET2-proteins, becomes methylated independent of the expression of PU.1. This results in complete de-modification of the PU.1 promoter also in cells where PU.1 is expressed under normal conditions. The affected cells express PU.1 at an intermediate level and thus are assumed to remain in the expansive niche (see cell type definition). This copes the phenotype known from so-called “blast cells” (SC′), which show PU.1 hypermethylation and are proliferative active [41]. Simulations of the system (Figure 6D,E and Appendix F, Figure A5E,F) actually show that nearly all cells become fixed in the unmodified and DNA methylated state immediately after the TET2 mutation is induced (t = 50).

The system can be re-transformed by external triggered DNA demethylation but will fall back into the blast system in case this trigger is taken away. In contrast to recruited DNA demethylation, external triggered DNA demethylation (e.g., applying DNMT1 inhibitors) will affect all expression states in the same way and thus induces the bivalent and not the unmodified state. Under such forced DNA demethylation the PU.1 expression might be similar to the un-mutated system, but the specification of P1 and P2 is enforced by higher and not by lower cell division frequency (see discussion).

4. Discussion

Transcriptional feedback loops that enable switches between gene expression states have been identified as basic motifs of gene regulatory networks [42]. Combination of feedback mechanism allows triggering decision processes between alternative gene expression programs. Histone modifications have been originally thought to stabilize the so achieved states [43]. Nevertheless, bivalent modifications have early been implicated also in decision making regarding developmental and stem cell differentiation processes [6]. Here, we provided a mechanistic model on how they might confer their regulatory capacity. In our model, both the activity of TFs as well as cell division events can change the state of bivalent modified promoters. Accordingly, circuits of bivalent genes can be considered as responsive or instructive, respectively. The latter because cell division can not only induce switches between histone modification states [3], but can also robustly trigger cell intrinsic decision processes. In contrast to extrinsically triggered decisions, these decisions do not require a heterogeneous or fluctuating environment. They only require random distribution of histones from the mother onto the daughter cells. Thereby, cell cycle time affects the proportions of decision making. Consequently, the model predicts proliferation activities to be essential for gene expression heterogeneity. Interestingly, a recent report on bivalent genes suggests that in fast proliferating cells, as ESCs, histone modification is under cell cycle control [44].

We focused on the case where the nucleosomes associated with the gene promoter carry both H3K4me3 and H3K27me3. ChIP-seq measurements alone do not provide this information and cannot distinguish this case from a case where a fraction of cells carries one and the complementary fraction the other modification. However, such kind of heterogeneity might be equally important for lineage specification and developmental processes as shown for H3K27me3 heterogeneity [45].

Our theoretical studies build on previous results of our group on the dynamics of histone modifications that are set by HMTs, being part of protein complexes that can read the modification. The gene promoters bound by these HMTs can assume bi-stable modification states capable of encoding a memory. Similar approaches have been published for the first time by Dodd et al. [46,47]. More complex models of cooperative pattern formation of histone modifications have been suggested by Anink-Groenen et al. [48]. Here, we studied a model combining histone modifications that can activate and repress gene transcription. Such a circuit has also been approached mathematically by Ku et al. but without a direct link between histone modification and transcription [49]. The regulation proposed by our model defines a set of histone modification states that can be realized in general, while the specific coupling of the gene’s transcription to the modifications specifies the states that are actually realized under given conditions. Thus, our approach allows separating the properties of the regulatory circuit that rely on the histone modification machinery from those relying on the TF-network. Thereby, existence of bivalency depends, among others, on the accessibility of the promoter.

In our model, DNA methylation de-stabilizes bivalent states reducing the effective binding energy of the HMTs to the promoter, i.e., reducing its accessibility. Such de-stabilization can induce an unmodified histone state. We have shown that introducing active DNA demethylation, gene expression heterogeneity can also result from this unmodified state as a consequence of successive DNA demethylation during the cell cycle; increasing the accessibility again. Assuming that the effectiveness of this process depends on the expression of the gene, first activated and at later times also repressed genes become DNA demethylated. Thus, also in this case, cell cycle time affects gene expression heterogeneity. Consequently, the response of gene expression heterogeneity on changing proliferation activities might dependent of the promoter methylation dynamics of the gene under consideration. Recent experimental findings suggest that they show large clonal differences [35].

We applied our circuits to explain gene expression heterogeneity in hematopoietic cells. The examples provided describe qualitative features of expression heterogeneity of two genes encoding basic TFs of hematopoietic lineage specification, GATA3 and PU.1. Activation of these genes is known to be associated with an increased potential to specify into lymphoid and myeloid lineages, respectively. These models may not qualify to explain the entire specification process into these two lineages, as e.g., [36], but they provide, for the first time, clear hypotheses on how histone modification might be involved. Thereby, the models are consistent with different experimental findings on histone modification profiles of HSCs and their progeny. Formally, they could be used to fit fluorescence-activated cell sorting (FACS) data on the decision process, but this would overstress their potential at the current state of the art.

The two examples (GATA3, PU.1) were chosen as closely related as possible, sharing all parameters of the histone and transcriptional machinery. This allows us to demonstrate that the introduction of DNA methylation can impair one regulatory principal while potentially introducing a “complementary” one. Thus, tight regulation of DNA methylation is an essential mechanism not only controlling bivalency but also a regulatory mechanism during lineage specification in general.

Our AML model bases on break down of an active lineage specification mechanism. Under normal conditions, self-renewal of the stem cells (SC) requires DNA methylation, in agreement with experimental findings on HSC self-renewal [50], and specification of P1 requires active DNA demethylation. Loss of demethylation, i.e., of the active lineage specification mechanism, induces hypermethylation of the PU.1 promoter and a differentiation block in agreement with experimental findings in AML [39] as well. Such loss of demethylation can be expected in about 28% of AML cases, where either the TET2 gene or the isocitrate dehydrogenase 1/2 (IDH1/2) genes are mutated [51]. Beside PU.1 many other demethylation targets are affected in these cases. However, a similar affect can be expected by down-regulation of PU.1 alone, as TET2 is recruited to PU.1 binding sites. Consistently, a moderate down-regulation of PU.1 indeed is sufficient to induce AML in mice [52]. Moreover, in about 26% of AML cases mutations of DNMT3a have been found [51]. Changes in DNMT3a function will affect the DNA methylation efficiency and thus also affect the outcome of our model. However, we have shown that lineage specification in the PU.1 system can be repressed simply by accelerating proliferation. This agrees with experimental findings that DNMT3a-mediated promoter hypermethylation is rather a consequence of AML progression, in particular of enforced proliferation, than the origin of AML [53].

We already mentioned that, analog to PU.1, also systematic imbalance of the expression states of GATA3 can lead to tissue transformation and that loss of GATA3 has been found to induce B cell lymphoma [32]. In the last years, it has been shown that PU.1 and GATA3 interact to control the myeloid-lymphoid switch [31]. Thus, the models introduced here can be considered as basic modules of a more complex model of this essential switch in hematopoietic lineage specification.

5. Conclusions

In agreement with experimental observations, our model suggests that bivalent states are fostered by open chromatin and a high degree of cooperative binding of H3K4me3 and H3K27me3 HMTs. Loss of bivalency due to promoter de-modification subsequent to cell division can instruct gene expression. Accordingly, major effectors of gene expression heterogeneity are the kinetics of histone modification reactions and the cell cycle time. Decreasing the cell cycle time de-stabilizes the bivalent state. This could be experimentally tested, e.g., for the GATA3 promoter.

Such destabilization can also be achieved by DNA methylation, which potentially replaces bivalent by unmodified states. In such a case, active DNA demethylation during the cell cycle can instruct gene expression similar to loss of bivalency after cell division. In addition, here, emerging gene expression heterogeneity depends on the time scale of histone modification reactions and on the cell cycle time. We suggest that this kind of regulation is impaired during AML blast formation following loss of function mutation of the TET pathway.

Computational models of epigenetic regulation of transcription enable testing hypotheses on the interactions between different (activating and repressive) epigenetic marks. Thus, they can support a mechanistic understanding of chromatin dynamics and its impact on decision processes during development and lineage specification.

Acknowledgments

This study was supported by the Deutsche Forschungsgemeinschaft grant SPP1463 (grant number: GA637/4-1) and the Bundesministerium für Bildung und Forschung grant INDRA (grant number: 031A312).

Abbreviations

AML acute myeloid leukemia
HMT histone methyltransferase
DNMT DNA methyltransferase
TF transcription factor
MV1 model version 1
MV2 model version 2

Appendix A. Model of Histone Modification

Regulation of Histone Modification

The binding probabilities of the HMTs, θK (K = 4, 27), are calculated assuming a positive feedback between the presence of the histone mark K and the recruitment of its HMTs. Such a feedback has been demonstrated for both H3K4me3 and H3K27me3 [1]. According to this assumption, the binding probability of the HMT of histone mark K depends on the fraction mK (K = 4, 27) of modified nucleosomes of the NH cooperative nucleosomes associated with the promoter and is given by:

θK=11+exp(ε0K+(1mDNA)εBSK+mKεHMKNH+λKlog(T)) (A1)

where ε0K is the ground enthalpy per bound HMT complex and εBSK and εHMK are the free energies of HMT binding to DNA and to histone mark K, respectively. They are specific for histone mark K and are scaled by the Boltzmann unit. A decrease (increase) of ε0K describes an increase (decrease) of the promoter accessibility. In this way, System A1 was changed to A2 by decreasing ε0K by 2.

For MV1 (stable DNA methylation), the fraction of methylated CpGs of the promoter mDNA is a constant. Setting mDNA = 0, we describe a completely unmethylated promoter DNA. In MV2, mDNA can vary (see: Appendix E). The factor λk is −1 for H3K4me3 and +1 for H3K27me3. Assuming a dynamic equilibrium between modification and de-modification, ΘK has to solve:

θK=CKmK1mK (A2)

where CK is the de-modification constant CK = kde/kmod; i.e., the ratio between the de-modification rate kde and the modification rate kmod for the respective modification. Using Equation (A2), rearrangement of Equation (A1) according to log10(T) yields:

log10(T)=ln(1mKCKmK1)(ε0K+(1mDNA)εBSK+mKεHMK)λK (A3)

where K specifies the modification, i.e., T = T1 (K = 4) and T = T2 (K = 27) as described in the text.

Changes of the solutions of Equations (1)–(3) according to parameter changes are often hard to follow in a linear plot of m27 versus m4. We therefore used a transformation of both variables which spreads their values if they approach their minimum and maximum. We used: mK* = 4000 − 500 × ln((mmax − mK)/mK), with mmax being the maximum modification level of the respective modification, given by: 1/(1 + CK) [3].

Table A1.

Parameter set {X} of the histone modification machinery. * scaled by the Boltzmann unit.

Parameter Value Description
ε04, ε027 9.0, 10.0 ground enthalpy per bound HMT *
εBS4, εBS27 −5.0, −5.0 free energy of CpG binding *
εHM4, εHM27 −0.5, −0.5 free energy of histone binding *
C4, C27 0.1, 0.1 de-modification constant
NH 4/12/20 number of cooperative nucleosomes

Appendix B. Model of Transcriptional Regulation

Regulation of Gene Expression

In the original model, we introduced a double positive feedback between transcription and the activating histone mark H3K4me3. Here, we extended the model by introducing a double negative feedback between transcription and the repressive histone mark H3K27me3 (see text). We assumed the transcription of the gene to depend on modification levels m4 and m27 of the gene promoter. Accordingly, the transcription of the individual genes is calculated by solving:

dTdt=Pmax((m0+m4)(1m27))1+Pmax1FTFFautoδT (A4)

where Pmax is the maximum promoter activity and δ the transcript degradation rate. FTF and Fauto are the regulation factors for the TF-network and the auto-regulation of the gene, respectively. The constant m0 << 1 ensures that genes can be transcribed with a small rate also if the promoter is devoid of H3K4me3 (m4 = 0). Details about the underlying regulatory principles, which are based on thermodynamics [54]. Fauto is given by:

Fauto=(1+Texp(εA)1+T)NTF (A5)

where εA is the decrease of the free energy of polymerase binding to the promoter, following auto-activation of the gene. It is scaled by the Boltzmann unit. NTF is the number of binding sites at the promoter for the TF encoded by the gene. Assuming a dynamic equilibrium of the transcription T, the function g of Equation (3) is given by:

(T)=Pmax(m0+m4)(1m27)1+(Pmax1)FTFFautoδ (A6)

Table A2.

Parameter set {Y} of the transcription machinery. Rates are given in events per simulation step. * scaled by the Boltzmann unit.

Parameter Value Description
Pmax 100 maximum transcription rate
δ 1.5 transcript degradation rate
εA 2 free energy of polymerase binding *
FTF 4/1/0.25 regulation factor of the TF-network
NTF 0/3 number of binding sites for auto-activation

Appendix C. Stochastic Simulation

In a first series of computer simulations of the model, we enabled changes of the histone modification level with defined rates, kde and kmod (CK = kde/kmod, K = 4, 27). In this series, we did not consider: (i) dilution of modifications due to cell division events; and (ii) active DNA demethylation. The so-defined stochastic system shows similar solutions as the deterministic one. This is shown in Figure A1 providing simulation results for systems without (NTF = 0) and with transcriptional feedback (NTF = 3). The borders between the attractors of the fix points are clearly separated from the fix points themselves. Thus, at the given level of fluctuations, transitions between the different states are rare, i.e., the states are stable over several cell cycles. Figure A2 demonstrates that DNA methylation destabilizes the bivalent state. For the simulations shown in Figure A1 and Figure A2, the parameter sets of the GATA3 and PU.1 system have been applied, respectively.

Figure A1.

Figure A1

Effects of stochastic histone (de-)modification I. Shown are results for the simulated distribution of histone modification states for a system: without (AC) (NTF = 0); and with (DF) (NTF = 3) transcriptional auto-activation. The color codes for transcription of the gene (A,D); and the frequency of the states (B,E) are as follows: blue, low; and red, high. All NH2 (400) possible initial states {m4, m27} have been considered in 100 realizations; (C,F) The basins of attraction separate the fix points (blue: H3K27me3, green: bivalent, red: H3K4me3).

Figure A2.

Figure A2

Effects of stochastic histone (de-)modification II. Shown are results for the simulated distribution of histone modification states for a system with transcriptional auto-activation (NTF = 3). In contrast to Figure A1D–F, DNA methylation changes are considered (Dnovo = 0.3). The color codes (blue: low, red: high) for transcription of the gene (A); the frequency of the states (B); and the basins of attraction (C) are as follows: blue, H3K27me3; green, bivalent; red, H3K4me3; and yellow, unmodified. Introducing DNA methylation, the basin of attraction of the attractor of the bivalent state shrinks (compare Figure A1F).

Appendix D. The GATA3 Circuit

Simulations of the GATA3 circuit have been performed using the parameter sets {X} and {Y} with NH = 20. As an exception, εHMK was changed to 0.55 for K = 4 and 27 in order to stabilize the bivalent state. In Figure A3, additional simulation results for system shown in Figure 4 are provided. Figure A3A–C demonstrates that the fix point of P2 is long term stable, as regeneration of the system from P2 cells takes up to 16 cell cycles (40 time steps). Figure A3D–F demonstrates that the population of bivalent cells expands if the cell cycle time τ is increased. Changes of the parameters of the epigenetic machinery lead to changes in the population heterogeneity. Figure A4 shows simulation results for the dependence of the systems composition on the absolute values of the histone modification rates.

Figure A3.

Figure A3

Regulatory states of the GATA3 circuit. Time dependent composition of the system, as seen for: transcription (A,D); H3K4me3 (B,E); and H3K27me3 (C,F) obtained in simulations with different initial conditions ((AC) P2 cells only, τ = τ0) and increased cell cycle time ((DF) τ = 10 τ0). The values are color coded. Black lines separate SC from P1 and P2 cells. In (DF), the regulatory states have been recorded every 1000th simulation steps to show the same number of cell cycles as in Figure 4D–F.

Figure A4.

Figure A4

Epigenetic de-regulation of the GATA3 circuit. Shown are simulation results demonstrating the dependence of the systems composition on the absolute values of the (de-)modification rates kmod and kde. At time t = 5, these rates are decreased: (A) for both modifications; (B) for H3K4me3 only; and (C) for H3K27me3 only, by a factor of 10, while their ratio CK remains conserved. All other parameters and color code are set as in Figure 4.

Appendix E. DNA Methylation Model

In order to calculate regulatory states of genes in the presence of DNA methylation, a simple model of DNA methylation was applied. This model considers the processes of maintenance and de novo DNA methylation at CpG rich promoters. Accordingly, the time derivative of the fraction of methylated CpGs within the promoter mDNA is given by:

τdmDNAdt=Dnovoh(m4,m27)(1mDNA)(1Dmain)mDNA (A7)

where Dmain and Dnovo are the maintenance and de novo DNA methylation probabilities, respectively. The function h depends on the histone modification state of the nucleosomes associated with the promoter. It is given by:

h=1+exp(DCG27m27)1+exp(DCG4m4DCG27m27) (A8)

where DCGK (K = 4, 27) are constants which describe the impact of histone modification K on binding of the de novo DNMT to the promoter. H3K4me3 methylation suppresses the binding. Thereby, DCG4 is the free energy change associated with binding at m4 = 1 scaled by the Boltzmann unit. Presence of H3K27me3 weakens the effect of H3K4me3, while at m4 = 0 it has no effect. Calculating solutions of Equations (1)–(3) in presence of DNA methylation, a stationary state dmDNA/dt = 0 is assumed (see Equation (4)). In stochastic simulations of the system, DNA methylation is updated after each cell division only, i.e., the Dmain and Dnovo are probabilities per cell division event.

In the model of the PU.1 circuit active DNA demethylation is assumed in addition. According to the experimental finding that binding of the PU.1 protein to the promoter recruits DNA demethylation enzymes (TET-proteins), the rate of (de-)modification is assumed to be PU.1 expression dependent. Thus, in the simulations, demethylation occurs with a rate:

DDE=DDE0TδPmax (A9)

where DDE0 is the maximum DNA demethylation rate per simulation step.

Table A3.

Parameter set {Z} of the DNA methylation machinery. Rates are given in events per simulation step. * scaled by the Boltzmann unit.

Parameter Value Description
Dmain 0.8 probability of maintaining DNA methylation
Dnovo 0.0/0.1/0.3 probability of de novo DNA methylation
DCG4, DCG27 6, 4 interaction energy between HMTs and DNMTs *
DDE0 6/2 maximum rate of active DNA demethylation

Appendix F. The PU.1 Circuit

Simulations of the PU.1 circuit have been performed using the same parameter sets as for the GATA3 circuit. DNA (de-)methylation was enabled applying the parameter set {Z} (see: Table A3).

Figure A5.

Figure A5

Histone states of the PU.1 circuit: (A,B) simulation results on the histone states of the system shown in Figure 6 ((A) H3K4me3; and (B) H3K27me3); and (C,D) results for the same system assuming an increase of the cell cycle time τ = 10τ0 ((C) H3K4me3l and (D) H3K27me3) enabling re-establishment of the bivalent state. The time is scaled to show the same number of cell cycles, as in (AF). Loss of function of the DNA demethylation in the blast system (at t = 50) leads to expansion of the unmodified state ((E) H3K4me3; and (F) H3K27me3). Black lines separate cell types. All values are color coded.

Figure A6.

Figure A6

Expansion of the SC population following accelerated proliferation. Shown are simulation results for the PU.1 circuit assuming an acceleration of the proliferation τ = 0.6τ0: (A) PU.1 expression; (B) H3K4me3; and (C) H3K27me3. The number of unmodified cells increases similar to the blast system. The time is scaled to show the same number of cell cycles as in Figure 6 and Figure A5A,B. All values are color coded.

Author Contributions

Torsten Thalheim developed the model source code, performed all simulations, analyzed data and contributed to writing; Maria Herberg analyzed data and contributed to writing; Markus Loeffler contributed ideas on modeling HSCs lineage priming; Joerg Galle supervised the study, analyzed data and wrote the main part of the article. All authors read and approved the final manuscript.

Conflicts of Interest

The authors declare no conflict of interests.

References

  • 1.Zhang T., Cooper S., Brockdorff N. The interplay of histone modifications—Writers that read. EMBO Rep. 2015;16:1467–1481. doi: 10.15252/embr.201540945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Cui K., Zang C., Roh T.Y., Schones D.E., Childs R.W., Peng W., Zhao K. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell. 2009;4:80–93. doi: 10.1016/j.stem.2008.11.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Binder H., Steiner L., Przybilla J., Rohlf T., Prohaska S., Galle J. Transcriptional regulation by histone modifications: Towards a theory of chromatin re-organization during stem cell differentiation. Phys. Biol. 2013;10:26006. doi: 10.1088/1478-3975/10/2/026006. [DOI] [PubMed] [Google Scholar]
  • 4.Voigt P., LeRoy G., Drury W.J., III, Zee B.M., Son J., Beck D.B., Young N.L., Garcia B.A., Reinberg D. Asymmetrically modified nucleosomes. Cell. 2012;151:181–193. doi: 10.1016/j.cell.2012.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sen S., Block K.F., Pasini A., Baylin S.B., Easwaran H. Genome-wide positioning of bivalent mononucleosomes. BMC Med. Genom. 2016;9:60. doi: 10.1186/s12920-016-0221-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., Fry B., Meissner A., Wernig M., Plath K., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell. 2006;125:315–326. doi: 10.1016/j.cell.2006.02.041. [DOI] [PubMed] [Google Scholar]
  • 7.Abraham B.J., Cui K., Tang Q., Zhao K. Dynamic regulation of epigenomic landscapes during hematopoiesis. BMC Genom. 2013;14:193. doi: 10.1186/1471-2164-14-193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Vincent A., Kazmierczak C., Duchêne B., Jonckheere N., Leteurtre E., van Seuningen I. Cryosectioning the intestinal crypt–villus axis: An ex vivo method to study the dynamics of epigenetic modifications from stem cells to differentiated cells. Stem Cell Res. 2015;14:105–113. doi: 10.1016/j.scr.2014.12.002. [DOI] [PubMed] [Google Scholar]
  • 9.Stojanova Z.P., Kwan T., Segil N. Epigenetic regulation of ATOH1 guides hair cell development in the mammalian cochlea. Development. 2016;143:1632. doi: 10.1242/dev.137976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Przybilla J., Rohlf T., Loeffler M., Galle J. Understanding epigenetic changes in aging stem cells—A computational model approach. Aging Cell. 2014;13:320–328. doi: 10.1111/acel.12177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Przybilla J., Buske P., Binder H., Galle J. Histone modifications control DNA methylation profiles during ageing and tumour expansion. Front. Life Sci. 2013;7:31–43. [Google Scholar]
  • 12.Buratowski S., Kim T. The role of cotranscriptional histone methylations. Cold Spring Harb. Symp. Quant. Biol. 2010;75:95–102. doi: 10.1101/sqb.2010.75.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Vermeulen M., Mulder K.W., Denissov S., Pijnappel W.W., van Schaik F.M., Varier R.A., Baltissen M.P., Stunnenberg H.G., Mann M., Timmers H.T. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell. 2007;131:58–69. doi: 10.1016/j.cell.2007.08.016. [DOI] [PubMed] [Google Scholar]
  • 14.Jermann P., Hoerner L., Burger L., Schübeler D. Short sequences can efficiently recruit histone H3 lysine 27 trimethylation in the absence of enhancer activity and DNA methylation. Proc. Natl. Acad. Sci. USA. 2014;111:E3415–E3421. doi: 10.1073/pnas.1400672111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pasini D., Malatesta M., Jung H.R., Walfridsson J., Willer A., Olsson L., Skotte J., Wutz A., Porse B., Jensen O.N., et al. Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of polycomb group target genes. Nucleic Acids Res. 2010;38:4958–4969. doi: 10.1093/nar/gkq244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jones P.A. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 2012;13:484–492. doi: 10.1038/nrg3230. [DOI] [PubMed] [Google Scholar]
  • 17.Ooi S.K., Qiu C., Bernstein E., Li K., Jia D., Yang Z., Erdjument-Bromage H., Tempst P., Lin S.P., Allis C.D., et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature. 2007;448:714–717. doi: 10.1038/nature05987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Thomson J.P., Skene P.J., Selfridge J., Clouaire T., Guy J., Webb S., Kerr A.R., Deaton A., Andrews R., James K.D., et al. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature. 2010;464:1082–1086. doi: 10.1038/nature08924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rush M., Appanah R., Lee S., Lam L.L., Goyal P., Lorincz M.C. Targeting of EZH2 to a defined genomic site is sufficient for recruitment of DNMT3a but not de novo DNA methylation. Epigenetics. 2009;4:404–414. doi: 10.4161/epi.4.6.9392. [DOI] [PubMed] [Google Scholar]
  • 20.Mutskov V., Felsenfeld G. Silencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9. EMBO J. 2004;23:138–149. doi: 10.1038/sj.emboj.7600013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dar R.D., Razooky B.S., Singh A., Trimeloni T.V., McCollum J.M., Cox C.D., Simpson M.L., Weinberger L.S. Transcriptional burst frequency and burst size are equally modulated across the human genome. Proc. Natl. Acad. Sci. USA. 2012;109:17454–17459. doi: 10.1073/pnas.1213530109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Alabert C., Barth T.K., Reverón-Gómez N., Sidoli S., Schmidt A., Jensen O.N., Imhof A., Groth A. Two distinct modes for propagation of histone PTMs across the cell cycle. Genes Dev. 2015;29:585–590. doi: 10.1101/gad.256354.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Galle J., Loeffler M., Drasdo D. Modeling the effect of deregulated proliferation and apoptosis on the growth dynamics of epithelial cell populations in vitro. Biophys. J. 2005;88:62–75. doi: 10.1529/biophysj.104.041459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Efroni S., Duttagupta R., Cheng J., Dehghani H., Hoeppner D.J., Dash C., Bazett-Jones D.P., Le Grice S., McKay R.D., Buetow K.H., et al. Global transcription in pluripotent embryonic stem cells. Cell Stem Cell. 2008;2:437–447. doi: 10.1016/j.stem.2008.03.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Okuno Y., Huang G., Rosenbauer F., Evans E.K., Radomska H.S., Iwasaki H., Akashi K., Moreau-Gachelin F., Li Y., Zhang P., et al. Potential autoregulation of transcription factor PU.1 by an upstream regulatory element. Mol. Cell. Biol. 2005;25:2832–2845. doi: 10.1128/MCB.25.7.2832-2845.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Schuijers J., Junker J.P., Mokry M., Hatzis P., Koo B.K., Sasselli V., van der Flier L.G., Cuppen E., van Oudenaarden A., Clevers H. ASCL2 acts as an R-spondin/Wnt-responsive switch to control stemness in intestinal crypts. Cell Stem Cell. 2015;16:158–170. doi: 10.1016/j.stem.2014.12.006. [DOI] [PubMed] [Google Scholar]
  • 27.Weishaupt H., Sigvardsson M., Attema J.L. Epigenetic chromatin states uniquely define the developmental plasticity of murine hematopoietic stem cells. Blood. 2010;115:247–256. doi: 10.1182/blood-2009-07-235176. [DOI] [PubMed] [Google Scholar]
  • 28.Attema J.L., Papathanasiou P., Forsberg E.C., Xu J., Smale S.T., Weissman I.L. Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis. Proc. Natl. Acad. Sci. USA. 2007;104:12371–12376. doi: 10.1073/pnas.0704468104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zhou M., Ouyang W. The function role of GATA-3 in Th1 and Th2 differentiation. Immunol. Res. 2003;28:25–37. doi: 10.1385/IR:28:1:25. [DOI] [PubMed] [Google Scholar]
  • 30.Van de Walle I., Dolens A.C., Durinck K., De Mulder K., Van Loocke W., Damle S., Waegemans E., de Medts J., Velghe I., de Smedt M., et al. GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fate. Nat. Commun. 2016;7:11171. doi: 10.1038/ncomms11171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Del Real M.M., Rothenberg E.V. Architecture of a lymphomyeloid developmental switch controlled by PU.1, Notch and GATA3. Development. 2013;140:1207–1219. doi: 10.1242/dev.088559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Liu S., Chan H.L., Bai F., Ma J., Scott A., Robbins D.J., Capobianco A.J., Zhu P., Pei X.H. GATA3 restrains B cell proliferation and cooperates with p18INK4c to repress B cell lymphomagenesis. Oncotarget. 2016;7:64007–64020. doi: 10.18632/oncotarget.11746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Shaknovich R., Melnick A. Epigenetics and B-cell Lymphoma. Curr. Opin. Hematol. 2011;18:293–299. doi: 10.1097/MOH.0b013e32834788cf. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Rakyan V.K., Down T.A., Maslau S., Andrew T., Yang T.P., Beyan H., Whittaker P., McCann O.T., Finer S., Valdes A.M., et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res. 2010;20:434–439. doi: 10.1101/gr.103101.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Franzen J., Zirkel A., Blake J., Rath B., Benes V., Papantonis A., Wagner W. Senescence-associated DNA methylation is stochastically acquired in subpopulations of mesenchymal stem cells. Aging Cell. 2017;16:183–191. doi: 10.1111/acel.12544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kueh H.Y., Champhekar A., Nutt S.L., Elowitz M.B., Rothenberg E.V. Positive feedback between PU.1 and the cell cycle controls myeloid differentiation. Science. 2013;341:670–673. doi: 10.1126/science.1240831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Amaravadi L., Klemsz M.J. DNA methylation and chromatin structure regulate PU.1 expression. DNA Cell Biol. 1999;18:875–884. doi: 10.1089/104454999314737. [DOI] [PubMed] [Google Scholar]
  • 38.De la Rica L., Rodríguez-Ubreva J., García M., Islam A.B., Urquiza J.M., Hernando H., Christensen J., Helin K., Gómez-Vaquero C., Ballestar E. PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation. Genome Biol. 2013;14:R99. doi: 10.1186/gb-2013-14-9-r99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Tatetsu H., Ueno S., Hata H., Yamada Y., Takeya M., Mitsuya H., Tenen D.G., Okuno Y. Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth. Cancer Res. 2007;67:5328–5336. doi: 10.1158/0008-5472.CAN-06-4265. [DOI] [PubMed] [Google Scholar]
  • 40.Sonnet M., Claus R., Becker N., Zucknick M., Petersen J., Lipka D.B., Oakes C.C., Andrulis M., Lier A., Milsom M.D., et al. Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia. Genome Med. 2014;6:34. doi: 10.1186/gm551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Schnerch D., Yalcintepe J., Schmidts A., Becker H., Follo M., Engelhardt M., Wäsch R. Cell cycle control in acute myeloid leukemia. Am. J. Cancer Res. 2012;2:508–528. [PMC free article] [PubMed] [Google Scholar]
  • 42.Alon U. Network motifs: Theory and experimental approaches. Nat. Rev. Genet. 2007;8:450–461. doi: 10.1038/nrg2102. [DOI] [PubMed] [Google Scholar]
  • 43.Chen T., Dent S.Y. Chromatin modifiers and remodellers: Regulators of cellular differentiation. Nat. Rev. Genet. 2014;15:93–106. doi: 10.1038/nrg3607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Grandy R.A., Whitfield T.W., Wu H., Fitzgerald M.P., van Oudenhove J.J., Zaidi S.K., Montecino M.A., Lian J.B., van Wijnen A.J., Stein J.L., et al. Genome-wide studies reveal that H3K4me3 modification in bivalent genes is dynamically regulated during the pluripotent cell cycle and stabilized upon differentiation. Mol. Cell. Biol. 2015;36:615–627. doi: 10.1128/MCB.00877-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Viré E., Brenner C., Deplus R., Blanchon L., Fraga M., Didelot C., Morey L., van Eynde A., Bernard D., Vanderwinden J.M., et al. The polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439:871–874. doi: 10.1038/nature04431. [DOI] [PubMed] [Google Scholar]
  • 46.Dodd I.B., Micheelsen M.A., Sneppen K., Thon G. Theoretical analysis of epigenetic cell memory by nucleosome modification. Cell. 2007;129:813–822. doi: 10.1016/j.cell.2007.02.053. [DOI] [PubMed] [Google Scholar]
  • 47.Sneppen K., Dodd I.B. A simple histone code opens many paths to epigenetics. PLoS Comput. Biol. 2012;8:e1002643. doi: 10.1371/journal.pcbi.1002643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Anink-Groenen L.C., Maarleveld T.R., Verschure P.J., Bruggeman F.J. Mechanistic stochastic model of histone modification pattern formation. Epigenet. Chromatin. 2014;7:30. doi: 10.1186/1756-8935-7-30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ku W.L., Girvan M., Yuan G.C., Sorrentino F., Ott E. Modeling the dynamics of bivalent histone modifications. PLoS ONE. 2013;8:e77944. doi: 10.1371/journal.pone.0077944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Bröske A.M., Vockentanz L., Kharazi S., Huska M.R., Mancini E., Scheller M., Kuhl C., Enns A., Prinz M., Jaenisch R., et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat. Genet. 2009;41:1207–1215. doi: 10.1038/ng.463. [DOI] [PubMed] [Google Scholar]
  • 51.Cancer Genome Atlas Research Network Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 2013;368:2059–2074. doi: 10.1056/NEJMoa1301689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Rosenbauer F., Wagner K., Kutok J.L., Iwasaki H., Le Beau M.M., Okuno Y., Akashi K., Fiering S., Tenen D.G. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 2004;36:624–630. doi: 10.1038/ng1361. [DOI] [PubMed] [Google Scholar]
  • 53.Spencer D.H., Russler-Germain D.A., Ketkar S., Helton N.M., Lamprecht T.L., Fulton R.S., Fronick C.C., O’Laughlin M., Heath S.E., Shinawi M., et al. CpG island hypermethylation mediated by DNMT3A is a consequence of AML Progression. Cell. 2017;168:801–816. doi: 10.1016/j.cell.2017.01.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Binder H., Wirth H., Galle J. Gene expression density profiles characterize modes of genomic regulation: Theory and experiment. J. Biotechnol. 2010;149:98–114. doi: 10.1016/j.jbiotec.2010.02.002. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Molecular Sciences are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES